GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (HAM:MAH0) » Definitions » FCF Yield %

Mereo BioPharma Group (HAM:MAH0) FCF Yield % : -2.64 (As of Sep. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mereo BioPharma Group FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mereo BioPharma Group's Trailing 12-Month Free Cash Flow is €-15.34 Mil, and Market Cap is €563.09 Mil. Therefore, Mereo BioPharma Group's FCF Yield % for today is -2.64%.

The historical rank and industry rank for Mereo BioPharma Group's FCF Yield % or its related term are showing as below:

HAM:MAH0' s FCF Yield % Range Over the Past 10 Years
Min: -11.77   Med: -5.86   Max: -2.64
Current: -2.64


During the past 9 years, the highest FCF Yield % of Mereo BioPharma Group was -2.64%. The lowest was -11.77%. And the median was -5.86%.

HAM:MAH0's FCF Yield % is ranked better than
76.4% of 1534 companies
in the Biotechnology industry
Industry Median: -13.655 vs HAM:MAH0: -2.64

Mereo BioPharma Group's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.


Mereo BioPharma Group FCF Yield % Historical Data

The historical data trend for Mereo BioPharma Group's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group FCF Yield % Chart

Mereo BioPharma Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only - - - - -

Mereo BioPharma Group Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -8.45 -6.03

Competitive Comparison of Mereo BioPharma Group's FCF Yield %

For the Biotechnology subindustry, Mereo BioPharma Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mereo BioPharma Group's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's FCF Yield % falls into.



Mereo BioPharma Group FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mereo BioPharma Group's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-19.762 / 0
=N/A%

Mereo BioPharma Group's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-7.342 * 4 / 487.43188
=-6.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mereo BioPharma Group FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Mereo BioPharma Group FCF Yield % Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mereo BioPharma Group Business Description

Comparable Companies
Traded in Other Exchanges
Address
One Cavendish Place, 4th Floor, London, GBR, W1G 0QF
Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Mereo BioPharma Group Headlines

No Headlines